Clinical StudyRole of cerebrolysin (cas 12656-61-0) in cervical spondylotic myelopathy patients: a prospective randomized study
-
Add time:08/21/2019 Source:sciencedirect.com
Background Contextcerebrolysin (cas 12656-61-0) is a mixture containing 85% free amino acids and 15% biologically active low–molecular weight peptides that is believed to mimic the effects of endogenous neurotrophic factors to interact with the pathologic process cascade of neurodegenerative diseases. No study has examined the effect of Cerebrolysin on cervical myelopathic patients.
We also recommend Trading Suppliers and Manufacturers of cerebrolysin (cas 12656-61-0). Pls Click Website Link as below: cas 12656-61-0 suppliers
Prev:Ameliorative effects of cerebrolysin (cas 12656-61-0) against isoproterenol-induced myocardial injury in male rats
Next:cerebrolysin (cas 12656-61-0) attenuates ethanol-induced spatial memory impairments through inhibition of hippocampal oxidative stress and apoptotic cell death in rats) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- cerebrolysin (cas 12656-61-0) attenuates ethanol-induced spatial memory impairments through inhibition of hippocampal oxidative stress and apoptotic cell death in rats08/22/2019
- Ameliorative effects of cerebrolysin (cas 12656-61-0) against isoproterenol-induced myocardial injury in male rats08/20/2019
- Subchronic cerebrolysin (cas 12656-61-0) treatment alleviates cognitive impairments and dendritic arborization alterations of granular neurons in the hippocampal dentate gyrus of rats with temporal lobe epilepsy08/19/2019
- Prospective, double blinded, comparative assessment of the pharmacological activity of cerebrolysin (cas 12656-61-0) and distinct peptide preparations for the treatment of embolic stroke08/18/2019
- Effect of cerebrolysin (cas 12656-61-0) on the cerebellum of diabetic rats: An imunohistochemical study08/17/2019
- Prevention of memory impairment induced by post-traumatic stress disorder by cerebrolysin (cas 12656-61-0)08/16/2019
- Original articleCardioprotective effects of cerebrolysin (cas 12656-61-0) on the lesion severity and inflammatory factors in a rat model of isoproterenol-induced myocardial injury08/15/2019